Literature DB >> 33664318

Risk factors for distant metastasis in locoregionally controlled oral squamous cell carcinoma: a retrospective study.

Hirofumi Tomioka1, Yuko Yamagata2, Yu Oikawa2, Toshimitsu Ohsako2, Takuma Kugimoto2, Takeshi Kuroshima2, Hideaki Hirai2, Hiroaki Shimamoto2, Hiroyuki Harada2.   

Abstract

The control of distant metastasis in oral squamous cell carcinoma is an important determinant of improved prognosis. The study aimed to identify risk factors for distant metastasis in patients with locoregionally controlled oral carcinoma. We identified 982 patients with oral squamous cell carcinoma treated at our hospital between January 2008 and December 2017. After excluding patients with distant metastasis at initial treatment, patients with metastasis to the oral cavity, those receiving palliative treatment, and those lacking follow-up data, 941 patients were selected. Finally, among these 941 patients, 887 with locoregionally controlled oral squamous cell carcinoma were included in the study. Among the 887 patients, 36 had confirmed distant metastasis (4.1%), and the lung was the most common site (31/36 patients, 86.1%). Multivariate analysis showed that the incidence of primary intraosseous carcinoma of the mandible, cervical lymph node metastasis at levels IV and V, and the presence of pathological extranodal extension were significant risk factors for distant metastasis. When treating patients with oral squamous cell carcinoma who are positive for the aforementioned risk factors, the possibility of developing distant metastases must be accounted for, and aggressive treatment should be planned accordingly.

Entities:  

Mesh:

Year:  2021        PMID: 33664318      PMCID: PMC7933271          DOI: 10.1038/s41598-021-84704-w

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  17 in total

Review 1.  Primary intraosseous carcinoma of the jaws.

Authors:  N Zwetyenga; J Pinsolle; J Rivel; C Majoufre-Lefebvre; A Faucher; V Pinsolle
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2001-07

2.  The role of pulmonary resection in tumors metastatic from head and neck carcinomas.

Authors:  Hiroyuki Daiko; Kanji Nagai; Junji Yoshida; Mitsuyo Nishimura; Tomoyuki Hishida; Mitsuru Ebihara; Masakazu Miyazaki; Takeshi Shinozaki; Shinpei Miyamoto; Minoru Sakuraba; Masahisa Saikawa; Ryuichi Hayashi
Journal:  Jpn J Clin Oncol       Date:  2010-03-08       Impact factor: 3.019

3.  Predictive factors of isolated distant metastasis after primary definitive surgery without systemic treatment for head and neck squamous cell carcinoma.

Authors:  Jae-Yol Lim; Young Chang Lim; Se-Heon Kim; Jae Wook Kim; Ha Min Jeong; Eun Chang Choi
Journal:  Oral Oncol       Date:  2010-04-18       Impact factor: 5.337

4.  Distant metastases in head and neck cancer.

Authors:  Fréderic Duprez; Dieter Berwouts; Wilfried De Neve; Katrien Bonte; Tom Boterberg; Philippe Deron; Wouter Huvenne; Sylvie Rottey; Marc Mareel
Journal:  Head Neck       Date:  2017-06-26       Impact factor: 3.147

5.  Predictive factors for distant metastasis from oral and oropharyngeal squamous cell carcinoma.

Authors:  Luiz Paulo Kowalski; André Lopes Carvalho; Antonio Vitor Martins Priante; José Magrin
Journal:  Oral Oncol       Date:  2005-04-09       Impact factor: 5.337

6.  Risk factors for distant metastases in head and neck squamous cell carcinoma.

Authors:  Werner Garavello; Alberto Ciardo; Roberto Spreafico; Renato Maria Gaini
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2006-07

7.  Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients.

Authors:  Jean-Pierre Pignon; Aurélie le Maître; Emilie Maillard; Jean Bourhis
Journal:  Radiother Oncol       Date:  2009-05-14       Impact factor: 6.280

8.  Platinum-based chemotherapy plus cetuximab in head and neck cancer.

Authors:  Jan B Vermorken; Ricard Mesia; Fernando Rivera; Eva Remenar; Andrzej Kawecki; Sylvie Rottey; Jozsef Erfan; Dmytro Zabolotnyy; Heinz-Roland Kienzer; Didier Cupissol; Frederic Peyrade; Marco Benasso; Ihor Vynnychenko; Dominique De Raucourt; Carsten Bokemeyer; Armin Schueler; Nadia Amellal; Ricardo Hitt
Journal:  N Engl J Med       Date:  2008-09-11       Impact factor: 91.245

9.  Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study.

Authors:  Barbara Burtness; Kevin J Harrington; Richard Greil; Denis Soulières; Makoto Tahara; Gilberto de Castro; Amanda Psyrri; Neus Basté; Prakash Neupane; Åse Bratland; Thorsten Fuereder; Brett G M Hughes; Ricard Mesía; Nuttapong Ngamphaiboon; Tamara Rordorf; Wan Zamaniah Wan Ishak; Ruey-Long Hong; René González Mendoza; Ananya Roy; Yayan Zhang; Burak Gumuscu; Jonathan D Cheng; Fan Jin; Danny Rischin
Journal:  Lancet       Date:  2019-11-01       Impact factor: 79.321

Review 10.  Radiation resistance in head and neck squamous cell carcinoma: dire need for an appropriate sensitizer.

Authors:  Marsha-Kay N D Hutchinson; Michelle Mierzwa; Nisha J D'Silva
Journal:  Oncogene       Date:  2020-03-10       Impact factor: 9.867

View more
  4 in total

1.  Effects of Red Blood Cell Transfusions on Distant Metastases of Oral Squamous Cell Carcinomas.

Authors:  Leonard Simon Brandenburg; Marc Christian Metzger; Philipp Poxleitner; Pit Jacob Voss; Kirstin Vach; Johannes Hell; Konstantin Hasel; Julia Vera Weingart; Steffen Jochen Schwarz; Michael Andreas Ermer
Journal:  Cancers (Basel)       Date:  2021-12-28       Impact factor: 6.639

2.  Study on the mechanism of SALL4 down-regulation in promoting the invasion and migration of oral squamous cell carcinoma and influencing the survival and prognosis of patients.

Authors:  Jin Li; Bin Zhang; Rongchen Xu; Bingxin Wang; Wenjun Hao; Xiaoxiao Zhang
Journal:  Ann Transl Med       Date:  2022-07

3.  High expression of Sam68 contributes to metastasis by regulating vimentin expression and a motile phenotype in oral squamous cell carcinoma.

Authors:  Takuya Komiyama; Takeshi Kuroshima; Takehito Sugasawa; Shin-Ichiro Fujita; Yuta Ikami; Hideaki Hirai; Fumihiko Tsushima; Yasuyuki Michi; Kou Kayamori; Fumihiro Higashino; Hiroyuki Harada
Journal:  Oncol Rep       Date:  2022-09-09       Impact factor: 4.136

Review 4.  Regulation of Ferroptosis by Non-Coding RNAs in Head and Neck Cancers.

Authors:  Pei-Ling Hsieh; Shih-Chi Chao; Pei-Ming Chu; Cheng-Chia Yu
Journal:  Int J Mol Sci       Date:  2022-03-15       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.